(Reuters) – Oxford University and AstraZeneca Plc have begun work to produce an Omicron-targeted version of their coronavirus vaccine, the Financial Times reported on Tuesday.
(Reporting by Maria Ponnezhath in Bengaluru; Editing by Leslie Adler)
Oxford, AstraZeneca launch work on Omicron-targeted vaccine – FT
Dec 21, 2021 | 3:17 PM
